Nimjee SM - Search Results

1

Nimjee SM, White RR, Becker RC, Sullenger BA. Nimjee SM, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:61-79. doi: 10.1146/annurev-pharmtox-010716-104558. Annu Rev Pharmacol Toxicol. 2017. PMID: 28061688 Free PMC article. Review.

2

The Sabiston vision of basic science in a department of surgery.

Nimjee SM, Sullenger BA. Nimjee SM, et al. Ann Surg. 2003 Dec;238(6 Suppl):S28-32. doi: 10.1097/01.sla.0000097106.09512.ab. Ann Surg. 2003. PMID: 14703741 No abstract available.

3

Antidote-mediated control of an anticoagulant aptamer in vivo.

Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G Jr, Scardino E, Fay WP, Sullenger BA. Rusconi CP, et al. Among authors: nimjee sm. Nat Biotechnol. 2004 Nov;22(11):1423-8. doi: 10.1038/nbt1023. Epub 2004 Oct 17. Nat Biotechnol. 2004. PMID: 15502817

4

Aptamers: an emerging class of therapeutics.

Nimjee SM, Rusconi CP, Sullenger BA. Nimjee SM, et al. Annu Rev Med. 2005;56:555-83. doi: 10.1146/annurev.med.56.062904.144915. Annu Rev Med. 2005. PMID: 15660527 Review.

5

The potential of aptamers as anticoagulants.

Nimjee SM, Rusconi CP, Harrington RA, Sullenger BA. Nimjee SM, et al. Trends Cardiovasc Med. 2005 Jan;15(1):41-5. doi: 10.1016/j.tcm.2005.01.002. Trends Cardiovasc Med. 2005. PMID: 15795162 Review.

6

Targeted inhibition of alphavbeta3 integrin with an RNA aptamer impairs endothelial cell growth and survival.

Mi J, Zhang X, Giangrande PH, McNamara JO 2nd, Nimjee SM, Sarraf-Yazdi S, Sullenger BA, Clary BM. Mi J, et al. Among authors: nimjee sm. Biochem Biophys Res Commun. 2005 Dec 16;338(2):956-63. doi: 10.1016/j.bbrc.2005.10.043. Epub 2005 Oct 21. Biochem Biophys Res Commun. 2005. PMID: 16256939

7

A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.

Nimjee SM, Keys JR, Pitoc GA, Quick G, Rusconi CP, Sullenger BA. Nimjee SM, et al. Mol Ther. 2006 Sep;14(3):408-15. doi: 10.1016/j.ymthe.2006.04.006. Epub 2006 Jun 9. Mol Ther. 2006. PMID: 16765093 Free article.

8

Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers.

Oney S, Nimjee SM, Layzer J, Que-Gewirth N, Ginsburg D, Becker RC, Arepally G, Sullenger BA. Oney S, et al. Among authors: nimjee sm. Oligonucleotides. 2007 Fall;17(3):265-74. doi: 10.1089/oli.2007.0089. Oligonucleotides. 2007. PMID: 17854267 Free article.

9

Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.

Nimjee SM, Oney S, Volovyk Z, Bompiani KM, Long SB, Hoffman M, Sullenger BA. Nimjee SM, et al. RNA. 2009 Dec;15(12):2105-11. doi: 10.1261/rna.1240109. Epub 2009 Oct 21. RNA. 2009. PMID: 19846574 Free PMC article.

10

RNA aptamer therapy for vaso-occlusion in sickle cell disease.

Burnette AD, Nimjee SM, Batchvarova M, Zennadi R, Telen MJ, Nishimura J, Sullenger BA. Burnette AD, et al. Among authors: nimjee sm. Nucleic Acid Ther. 2011 Aug;21(4):275-83. doi: 10.1089/nat.2010.0270. Epub 2011 Jun 28. Nucleic Acid Ther. 2011. PMID: 21793788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page